Status:
COMPLETED
Emergency Medicine Palliative Care Access
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
Beaumont Health
Dana-Farber/Brigham and Women's Cancer Center
Conditions:
Advanced Cancer
End Stage Organ Failure
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
This is a two-arm, multi-site randomized controlled trial of 1,350 older adults (50+ years) with either advanced cancer (defined as metastatic solid tumor) or poor prognosis end-stage organ failure (N...
Eligibility Criteria
Inclusion
- Patients:
- English or Spanish-speaking patients ages 50 years and older
- Qualifying serious, life-limiting conditions and who are scheduled for ED discharge, observation status, or admission for two midnights or less.
- Qualifying conditions include: advanced cancer (defined as metastatic solid tumor) or poor prognosis end-stage organ failure New York Heart Association (NYHA) Class III or IV Congestive Heart Failure (CHF), End-Stage Renal Disease (ESRD), defined as Glomerular Filtration Rate (GFR) \< 15 ml/min/m2 or dialysis; or Global Initiative for Chronic Obstructive Lung Disease (GOLD) Stage III or higher or stage III or IV, or oxygen-dependent chronic obstructive pulmonary disease (COPD) defined as Global Initiative for Chronic Obstructive Lung Disease (GOLD)
- Patients must have health insurance, reside within the geographical area, and have a working telephone.
- Informal Caregivers:
- English or Spanish-speaking primary caregivers (relative or friend who has contact with the patient at least two times per week) ages 18 years and older.
Exclusion
- Patients with dementia identified in the EHR, who received hospice services in the last six months, who have received 2 or more palliative care visits in the last 6 months, and those who reside in a skilled nursing or assisted living facility, or chronic care hospital.
Key Trial Info
Start Date :
March 28 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 24 2023
Estimated Enrollment :
1606 Patients enrolled
Trial Details
Trial ID
NCT03325985
Start Date
March 28 2018
End Date
August 24 2023
Last Update
January 13 2025
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Los Angeles Ronald Reagan Medical Center
Los Angeles, California, United States, 90095
2
University of California Irvine Medical Center
Orange, California, United States, 92868
3
University of California San Diego Medical Center
San Diego, California, United States, 92103
4
Yale University
New Haven, Connecticut, United States, 06510